News & Updates

Using these antigens, researchers plan to develop vaccine candidates that they hope would stimulate a strong immune response against the world’s deadliest pathogen.

Co-founded by Kanav Setia and Jason Necaise ’20, qBraid lets users access the most popular quantum devices and software programs on an intuitive, cloud-based platform.

MIT engineers developed a programmable drug-delivery patch that can promote tissue healing and blood vessel regrowth following a heart attack.

MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.

Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.

The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.

Selective crystallization can greatly improve the purity, selectivity, and active yield of viral vector-based gene therapy drugs, MIT study finds.

Adding amino acids to certain protein-based medications can improve stability and effectiveness. New MIT research demonstrates how it works.